Influence of inhaled corticosteroids on growth: A pediatric endocrinologist's perspective

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 2, 1998, Pages 123-129

  Allen, D B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Asthma; Glucocorticoids; Growth; Inhaled corticosteroids

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID;

ARTICLE; CHILD; CHILD GROWTH; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG MECHANISM; ENDOCRINOLOGY; GROWTH RETARDATION; HUMAN; INFLAMMATORY DISEASE; INHALATIONAL DRUG ADMINISTRATION; MEDICAL SPECIALIST; ORAL DRUG ADMINISTRATION; PEDIATRICS; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ASTHMA; CHILD; COLLAGEN; GLUCOCORTICOIDS; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; RECEPTORS, SOMATOTROPIN; RESEARCH DESIGN; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0031886377     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035259850157516     Document Type: Article

References (58)

1. Allen DB. Growth suppression by glucocorticoid therapy. In: Rosenfield RL, editor. Growth and Growth Disorders. Philadelphia: W.B. Saunders Company; 1996; 699-718
2. Allen DB. Inhaled corticosteroids in children. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed. St Louis: Mosby Yearbook; 1993 (Update 15): 6-16
3. Locascio V, Bonucci E, Imbimbo B. Bone loss in response to long term glucocorticoid therapy. Bone Miner 1990; 8: 39-51
4. Moore DD, Marks AR, Buckley DI, Kapler G, Payvar F, Goodman HM. The first intron of the human growth hormone gene contains a binding site for glucocorticoid receptor. Proc Natl Acad Sci U S A 1985; 82: 699-702
5. Lima L, Arce V, Diaz MJ, Tresguerres JAF, Devesa J. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons. J Clin Endocrinol Metab 1993; 76: 439-44
6. Guistina A, Wehrenberg WB. The role of glucocorticoids in the regulation of growth hormone secretion - mechanisms and clinical significance. Trends Endocrinol Metah 1992; 3: 306-11
7. Kaufmann S, Jones KL, Wehrenberg WB, Culler FL. Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men. J Clin Endocrinol Metab 1988; 67: 1258-61
8. Schaefer F, Hamill G, Stanhope R. Pulsatile growth hormone secretion in peripubertal patients with chronic renal failure. J Pediatr 1991; 119: 568-77
9. Spiliotis BE, August GP, Hung W. Growth hormone neurosecretory dysfunction. JAMA 1984; 257: 2223-6
10. Crowley S, Hindmarsh PC, Matthews DR, Brook CGD. Growth and the growth hormone axis in prepubertal children with asthma. J Pediatr 1995; 126: 297-303
11. Gabrielsson BG, Carmignac DF, Flavell DM, Robinson ICAF. Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology 1995; 136: 209-17
12. Unterman TG, Phillips LS. Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 1985; 61: 618-26
13. Hokken-Koelega ACS, Stijnen T, deMuinckKeizer-Schrama SMPF, Blum WF, Drop SLS. Levels of growth hormone, insulin-like growth factor I (IGF-I) and -II, IGF binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation. J Clin Endocrinol Metab 1993; 77: 932-8
14. Sarna S, Sipila I, Vihervuori E, Koistinen R, Holmberg C. Growth delay after liver transplantation in childhood: studies of underlying mechanisms. Pediatr Res 1995; 38: 366-72
15. Ristelli J. Effect of prednisolone on the activities of intracellular enzymes of collagen biosynthesis in rat liver and skin. Biochem Pharmacol 1977; 26: 1295-8
16. Hyams JS, Moore RE, Leichtner AM, Carey DE, Goldberg BD. Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease. J Pediatr 1988; 112: 893-8
17. Wolthers OD, Hansen M, Juul A, Nielsen HK, Pederson S. Knemometry, urine cortisol excretion, and measures of insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticoids. Pediatr Res 1997; 41: 44-50
18. Sadeghi-Nelad A, Semor B. Adrenal function, growth, and insulin in patients treated with corticoids on alternate days. Pediatrics 1969; 43: 277-83
19. Reimer LG, Morris HG, Ellis EE. Growth of asthmatic children during treatment with alternate-day steroids. J Allergy Clin Immunol 1975; 55: 224-31
20. Mosier HD. The determinants of catch-up growth. Acta Paediatr Scand 1990; 367: 126-9
21. Baron J, Klein KO, Colli MJ, Yanovski JA, Novosad JA, Bacher JD, Cutler GB. Catch-up growth after glucocorticoid excess: a mechanism intrinsic to the growth plate. Endocrinology 1994; 135: 1367-71
22. Tanner, JM. Growth as a target-seeking function. In: Falkner F, Tanner JM, editors. Human growth - a comprehensive treatise. New York: Plenum Press, 1990: 1671
23. Allen DB, Mullen M, Mullen B. A meta-analysis of the effects of oral and inhaled glucocorticoids on growth. J Allergy Clin Immunol 1994; 93: 967-76
24. Foote KD, Brocklebank JT, Meadow SR. Height attainment in children with steroid responsive nephrotic syndrome. Lancet 1985; ii: 917-76
25. Allen DB, Julius JR, Breen TJ, et al. Reversal of glucocorticoid-induced growth failure by human growth hormone [Abstract]. Pediatr Res 1996; 39: 84A
26. Ryrfelt A, Andersson P, Edsbacker S. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis 1982; 63 (Suppl 122): 86
27. Chaplin MD, Cooper WC, Segre EJ. Correlation of flunisolide plasma levels to eosinopenic response in humans. J Allergy Clin Immunol 1980; 65: 445
28. Ryrfeldt A, Edsbacker S, Pouwles R. Kinetics of epimeric glucocorticoid budesonide. Clin Pharmacol Therap 1984; 35: 525-30
29. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84 (Suppl A): 25-9
30. Pedersen S, Steffensen G, Ekman I, Tonnesson M, Borga O. Pharmacokinetics of budesonide in children with asthma. Eur J Clin Pharmacol 1987; 31: 579-82
31. Johansson SA, Andersson KE, Brattsand R. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol 1982; 22: 523
32. Johnson M. Pharmacokinetics and pharmacodynamics of inhaled glucocorticoids. J Clin Allergy Immunol 1996; 98: 169-76
33. Agertoft L, Pedersen S. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. J Allergy Clin Immunol 1997; 99(6): 773-80
34. Agertoft L, Pederson S. The importance of delivery system for the effect of Budesonide. Arch Dis Child 1993; 69: 130-3
35. Hollman GA, Allen DB. Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 1988; 81: 452-5
36. Ninan T, Russell G. Asthma, inhaled corticosteroid treatment, and growth. Arch Dis Child 1992; 67: 703-5
37. Ghigo E, Valetto M, Gaggero L, Visca A, Valente F, Bellone J, et al. Therapeutic doses of salbutamol inhibit the somatotropic responsiveness to growth hormone-releasing hormone in asthmatic children. J Endocrinol Invest 1993; 16: 271-6
38. Wolthers OD, Pederson S. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticoids. Pediatrics 1992; 89: 839-42
39. Wales JKH, Milner RDG. Knemometry in assessment of linear growth. Arch Dis Child 1987; 62: 166-71
40. Agertoft L, Pedersen S. Relationship between short-term lower leg growth and long-term statural growth in asthmatic children treated with budesonide [Abstract]. Eur Respir J 1996; 9 (Suppl 23): 294s
41. Hermanussen M, Burmeister J. Standards for the predictive accuracy of short-term body height and lower leg length measurements on half annual growth rates. Arch Dis Child 1989; 64: 259-63
42. Karlberg J, Gelander L, Albertsson-Wikland K. Distinctions between short- and long-term human growth studies. Acta Paediatr 1993; 82: 631-4
43. Littlewood JM, Johnson AW, Edwards PA. Growth retardation in asthmatic children treated with inhaled becomethasone dipropionate. Lancet 1988; i: 115
44. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic mild to moderately severe asthma in children. Pediatrics 1993; 92: 64-77
45. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995; 151: 1715-9
46. Verberne AAPH, Frost C, DipStat MA, Roorda RJ, van der Laag H, Kerribijn KF. One year treatment with salmeterol compared to beclomethasone in children with asthma. Am J Respir Crit Care Med 1997; 156: 688-95
47. Merkus PJFM, VanEssenZandvliet EEM, Duiverman EJ, VanHouwelingen HC, Kerrebijn KF. Long term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993; 91: 1121-6
48. Balfour-Lynn L. Growth and childhood asthma. Arch Dis Child 1986; 61: 1049-55
49. Allen DB, Bronsky EA, LaForce CF, Nathan RA, Tinkelman DG, Vandewalker ML, Konig P. Growth in asthmatic children treated with fluticasone propionate. J Pediatr 1997; in press
50. Volovitz B, Amir J, Malik H, Kauschansky A, Varsano I. Growth and pituitary adrenal function in children with severe asthma treated with inhaled budesonide. N Eng J Med 1993; 329: 1703-8
51. Agertoft L, Pederson S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-81
52. Lemanske RF, Allen DB. Choosing a long-term controller medication in childhood asthma: the proverbial two-edged sword. Am J Respir Crit Care Med 1997; 156: 685-7
53. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 1051-7
54. Edsbacker S, Andersson KE, Ryrfeldt A. Nasal bioavailability and system effects of the glucocorticoid budesonide in man. Eur J Clin Pharmacol 1985; 29: 477-81
55. Wolthers OD, Pedersen S. Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Paediatr 1993; 82: 635-40
56. Wolthers OD, Pedersen S. Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children. Allergy 1994; 49: 96-9
57. Moller C, Sandahl G, Henricson K, et al. An open long-term study of budesonide in children with perennial rhinitis [Abstract]. Clin Exp Allergy 1990; 20 (Suppl 1): 101
58. Moller C, Ek L, Svennson I. Nasal budesonide to children for 5 years [Abstract]. Allergy Clin Immunol News 1994; 6 (Suppl 2): 427